Santen Pharmaceuticals Announces Strategic Investment in Regenerative Patch Technologies LLC

Santen Pharmaceuticals, Co., Ltd.

Represented Santen Pharmaceuticals, Co., Ltd. of Osaka, Japan in connection with a strategic investment in Regenerative Patch Technologies, LLC, an early stage company located in the Bay Area, which is developing stem cell therapies for treatment of retinal diseases. Financial terms were undisclosed. 

Santen Pharmaceuticals, Co., Ltd. is a leading ophthalmic company that focuses on the research, development, marketing and sales of pharmaceuticals. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and currently sells its products in over 50 countries.

Newport Beach-based Larry Cohn represented Santen Pharmaceuticals in this transaction.